ChemOvation

Executive Summary

ChemOvation is a UK-based life sciences consultancy founded in 2014 by Dr. Ian Matthews, specializing in small molecule and drug delivery innovation. The company provides expert medicinal chemistry, process R&D, and drug discovery services to pharmaceutical and biotechnology clients. As an independent consultancy, ChemOvation leverages deep domain expertise to accelerate drug development programs. Its pre-clinical stage position and service-based model position it as a flexible partner in the evolving outsourced R&D market. The company is privately held and has not disclosed funding rounds or valuation, reflecting its consultancy nature.

Upcoming Catalysts (preview)

• Q3 2026Announcement of a strategic partnership with a tier-1 pharmaceutical company60% success
• Q4 2026Expansion of service offerings into oncology or CNS therapeutic areas50% success